AstraZeneca PLC
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca Rare Disease (Alexion) — Established RoW YoY CER by Quarter
Rare Disease (Alexion) — Established RoW YoY CER (%) (%)
AstraZeneca Rare Disease (Alexion) — Established RoW YoY CER: 20.0% in Q2 2026, up 18.0 pts from a year earlier.
Where the Q2 2026 figure comes from
“|| Rare Disease | | 2,490 | | 9 | | 8 | | 1,452 | | 8 | | 305 | | 10 | | 6 | | 442 | | 7 | | 3 | | 291 | | 13 | | 20”
Source: Form 6-K FY2026Q2 Earnings Release ↗
Reported in Form 6-K / 20-F Therapy Area Product Sales Table.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). AstraZeneca Rare Disease (Alexion) — Established RoW YoY CER (%), quarterly Q3 2021–Q2 2026 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/ta-rare-erow-cer-yoy
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.